Amir T Fathi

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Exploiting cellular pathways to develop new treatment strategies for AML
    Amir T Fathi
    Division of Hematologic Malignancies, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, Baltimore, MD 21231, USA
    Cancer Treat Rev 36:142-50. 2010
  2. ncbi Chemotherapy for advanced stage non-small cell lung cancer
    Amir T Fathi
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231 1000, USA
    Semin Thorac Cardiovasc Surg 20:210-6. 2008
  3. ncbi New agents in acute myeloid leukemia: beyond cytarabine and anthracyclines
    Amir T Fathi
    Division of Hematologic Malignancies, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, CRB 1 Room 289, Baltimore, MD 21231, USA
    Curr Oncol Rep 11:346-52. 2009

Detail Information

Publications3

  1. ncbi Exploiting cellular pathways to develop new treatment strategies for AML
    Amir T Fathi
    Division of Hematologic Malignancies, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, Baltimore, MD 21231, USA
    Cancer Treat Rev 36:142-50. 2010
    ..In this review, we aim to provide a summary of the preclinical and clinical investigations of selected promising agents currently under study...
  2. ncbi Chemotherapy for advanced stage non-small cell lung cancer
    Amir T Fathi
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231 1000, USA
    Semin Thorac Cardiovasc Surg 20:210-6. 2008
    ..Clinical trials have also recently demonstrated increased efficacy for agents such as docetaxel and pemetrexed in the second line setting for refractory disease...
  3. ncbi New agents in acute myeloid leukemia: beyond cytarabine and anthracyclines
    Amir T Fathi
    Division of Hematologic Malignancies, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, CRB 1 Room 289, Baltimore, MD 21231, USA
    Curr Oncol Rep 11:346-52. 2009
    ....